Start-ups founded by PRiME members attract major pharmaceutical interest
Start-up companies co-founded by PRiME faculty members, Sachdev Sidhu and Jason Moffat, have garnered the attention of major pharmaceutical partners, with several acquisitions transpiring over the last month. Earlier this week, Gilead Sciences purchased a stake in Pionyr Immunotherapeutics for $275M to access its Myeloid TuningTM approach to cancer immunotherapies. The technology, which is based […]